Tech leaders are sounding alarms over the potential misuse of synthetic DNA, which can be ordered online like any lab supply. While this technology has accelerated medical advancements, it also poses significant biosecurity risks. Bad actors could theoretically create dangerous pathogens by ordering specific DNA sequences, a concern that has grown as AI systems become more sophisticated.
The CEOs of major AI companies, including OpenAI and Microsoft, have urged the US Congress to implement safety screenings for synthetic DNA purchases. They argue that mandatory checks and record-keeping could deter misuse and enhance traceability, allowing authorities to track suspicious activities more effectively.
This issue extends beyond the US, with the European Commission also proposing regulations to address the biosecurity risks associated with biotechnology. The EU’s Biotech Act aims to create a unified framework for monitoring synthetic DNA transactions, reflecting similar concerns raised by tech giants.
As AI technology evolves, the barriers preventing misuse of biological materials are diminishing. Experts warn that without regulatory measures, the potential for bioweapons development could increase, highlighting the urgent need for global cooperation in biosecurity efforts.
Source: Euronews
